In silico synergism and antagonism of an anti-tumour system intervened by coupling immunotherapy and chemotherapy: a mathematical modelling approach (Q417370): Difference between revisions
From MaRDI portal
Created a new Item |
Changed an Item |
||
| Property / author | |||
| Property / author: Li Li / rank | |||
Normal rank | |||
| Property / Mathematics Subject Classification ID | |||
| Property / Mathematics Subject Classification ID: 92C50 / rank | |||
Normal rank | |||
| Property / Mathematics Subject Classification ID | |||
| Property / Mathematics Subject Classification ID: 92C45 / rank | |||
Normal rank | |||
| Property / zbMATH DE Number | |||
| Property / zbMATH DE Number: 6034332 / rank | |||
Normal rank | |||
| Property / zbMATH Keywords | |||
nonlinear dynamics | |||
| Property / zbMATH Keywords: nonlinear dynamics / rank | |||
Normal rank | |||
| Property / zbMATH Keywords | |||
synergism and antagonism | |||
| Property / zbMATH Keywords: synergism and antagonism / rank | |||
Normal rank | |||
| Property / zbMATH Keywords | |||
tumour | |||
| Property / zbMATH Keywords: tumour / rank | |||
Normal rank | |||
| Property / zbMATH Keywords | |||
numerical simulation | |||
| Property / zbMATH Keywords: numerical simulation / rank | |||
Normal rank | |||
| Property / zbMATH Keywords | |||
preclinical pharmacokinetics evaluation | |||
| Property / zbMATH Keywords: preclinical pharmacokinetics evaluation / rank | |||
Normal rank | |||
Revision as of 20:54, 29 June 2023
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In silico synergism and antagonism of an anti-tumour system intervened by coupling immunotherapy and chemotherapy: a mathematical modelling approach |
scientific article |
Statements
In silico synergism and antagonism of an anti-tumour system intervened by coupling immunotherapy and chemotherapy: a mathematical modelling approach (English)
0 references
14 May 2012
0 references
nonlinear dynamics
0 references
synergism and antagonism
0 references
tumour
0 references
numerical simulation
0 references
preclinical pharmacokinetics evaluation
0 references
